Your Notifications
All done, no notifications

CAR-T Cost in Jordan

Costs starts from USD60000 to USD80000
Filters

How Much Does CAR-T Cost in Jordan?

The estimated cost for a CAR-T in Jordan ranges between USD 60000 - USD 80000.

Costs associated with CAR-T therapy vary depending on multiple factors: the specific type of CAR-T product used, the level of modernity of the hospital system, the provider's professional skill set, and the patient's overall health before receiving CAR-T therapy. Additionally, pre-treatment testing, medication, supportive care, and complications occurring during CAR-T therapy (including cytokine release syndrome (CRS) and neurological complications) affect overall CAR-T therapy costs.

Factors Influencing the Cost of CAR-T

Cost of CAR-T in Major cities of Jordan

CityMinimum Cost (USD)Minimum Cost (JOD)Maximum Cost (USD)Maximum Cost (JOD)
AmmanUSD 6000042600USD 8000056800

CAR-T Cost : A Global Comparison

CountryMinimum CostMinimum Local CurrencyMaximum CostMaximum Local Currency
JordanUSD 60000JOD 42600USD 80000JOD 56800
VietnamUSD 30000VND 778950000USD 50000VND 1298250000

Need Help Planning Your Treatment Abroad?

Your 24/7 AI Health Assistant

CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.

This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.

Classification:

CAR T cell therapy is classified as follows:

  • Structure-based classification:
  • First-generation CAR T-cells: These CAR T-cells typically consist of an antigen-binding domain (single-chain variable fragment, scFv) linked to a T-cell activation domain, such as the CD3ζ chain. They lack additional co-stimulatory domains.
  • Second-generation CAR T-cells: These CAR T-cells include an additional co-stimulatory domain, such as CD28 or 4-1BB (CD137), along with the CD3ζ chain. The presence of co-stimulatory domains enhances T-cell activation and persistence.
  • Third-generation CAR T-cells: These CAR T-cells incorporate two co-stimulatory domains along with the CD3ζ chain, aiming to further enhance T-cell function and anti-tumor activity.

Antigen-based classification: It includes

  • CD19-targeted CAR T-cells: CD19 is a common target for CAR T-cell therapy and is used in the treatment of B-cell malignancies such as acute lymphoblastic leukemia (ALL) and certain types of lymphoma.
  • Other antigen-targeted CAR T-cells: CAR T-cells can be engineered to target a variety of antigens expressed on cancer cells, including but not limited to BCMA (B-cell maturation antigen), CD22, CD30, and EGFRvIII.

Would you like some help? We are available.

Get Help
Explore Hospitals ( 1 )
CAR-T in Arab Medical Center: Costs, Top Doctors, and Reviews

Amman, Jordan

  • Joint Commission International, or JCI
  • The hospital offers specialised and high-quality medical care to both local and international patients.
  • It offers 24/7 emergency services with experienced staff and dedicated rooms for children and patients with infectious diseases.
  • AMC performs advanced surgeries, including those for the brain, heart, bones, and eyes.
  • The hospital has modern medical equipment and diagnostic tools for accurate testing and treatment.
  • It includes speciality clinics for heart, cancer, brain, diabetes, and more.
  • AMC supports critical care units like the Intensive Care Unit (ICU), Coronary Care Unit (CCU), and dialysis unit.
  • It ensures patient comfort through clean rooms, professional service, and luxury accommodation options.
  • The hospital promotes medical education and awareness through services like the Arabi Podcast.
  • AMC actively supports medical tourism and is known as a trusted referral hospital in the region.
  • It focuses on continuous quality improvement and compassionate care for every patient.
  • AMC has a loyalty program (Arabi Care Card) that offers benefits and discounts to regular patients.
  • The hospital ensures easy accessibility due to its central location near major landmarks and hotels in Amman.

Need Some Advice From Our Experts?

Request a Call Back Now!

Our team of healthcare experts would be happy to assist you

trusted Patientstrusted Patients+99
Trusted by 50000+ Patients
Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Instantly Connect with our CAR-T Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Other Popular Countries for CAR-T

Our network connects you with the leading medical tourism destinations globally, offering a wide range of cities, top doctors, and flexible pricing options.

Thailand
United Kingdom
United Arab Emirates
Spain

Frequently Asked Questions

The best hospital in Jordan is:
  • Arab Medical Center
  • The time patients spend in the hospital after receiving CAR-T therapy can vary. In general, patients remain in a hospital for 1-2 weeks following CAR-T therapy to monitor for potential side effects, including CRS. When patients leave the hospital, they typically spend an additional 2-4 weeks recovering and receiving follow-up care. Full immune recovery may occur over several months, depending on the severity of the side effects developed during administration of CAR-T therapy, and ultimately, how well the patient responds to the treatment.

    Additional expenses may include:
  • Pre-operative tests (X-ray, MRI, blood work)
  • Anaesthesia fees
  • Post-surgery medications
  • Physiotherapy sessions
  • Follow-up consultations
  • If you're an international patient, costs for travel, accommodation, meals, and airport transfers.

    Amman is the primary city in Jordan for complex surgery and medical travel, and it has the largest concentration of JCI-accredited hospitals and surgeons with international training. Other areas offer limited services.

    Reasons why patients choose Jordan:
  • JCI-accredited modern Hospitals, with costs that are competitive with those in other countries
  • Packages that are well organised for international medical travel.
  • High-quality care from fellowship-trained surgeons with extensive experience.
  • Modern hospitals, accredited by JCI, offer a range of advanced arthroscopic and minimally invasive techniques.
  • Short waiting times for consultations with specialists, for imaging studies, and for surgery.
  • Strong rehabilitation service with structured physiotherapy programs.
  • There are differences in the success rates of CAR-T therapy across various cancer types. Patients with certain forms of blood cancer receive higher rates of complete remission than patients with other types of malignancies. Patients diagnosed with B-cell acute lymphoblastic leukaemia (B-ALL) who have experienced relapsed/refractory disease typically achieve complete remissions at rates of 80 to 90%.

    Yes, while CAR-T therapy is effective, it does pose certain risks (e.g., cytokine release syndrome [CRS] and neurotoxicity); however, with prompt monitoring and appropriate specialist management of these side effects, their impact can be mitigated.

    Candidates for CAR-T therapy will typically have blood cancers that have either relapsed or failed to respond to treatment (e.g., lymphoma, leukaemia, or multiple myeloma), are being evaluated medically, and are being assessed based on their prior treatment history.

    After receiving a CAR-T infusion, CAR-T patients typically require hospitalisation for monitoring for 1–2 weeks; however, the overall recovery period can take several weeks, depending on the severity of their side effects and individual patient response.

    Yes, patients must receive regular follow-up visits to check blood counts, recovery from treatment, and evaluate their long-term immune status.

    Author

    Dr. Vishwas Kaushik

    MBBS, MD

    5 Years of Experience

    Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication.. View More

    Reviewer

    Dr Prateek Varshney

    Surgical Oncologist

    15 Years of Experience

    Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More